GENEVA, May 5 -- GENFIT (885 avenue Eugene Avinee59120 LOOS) filed a patent application (PCT/EP2024/080132) for "ELAFIBRANOR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS" on Oct 24, 2024. With publication no. WO/2025/088067, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BIRMAN, Pascal (20 rue d'Edimbourg75008 PARIS), ROUDOT, Alice (365, avenue de Dunkerque59160 LOMME), MAGREZ, David (83 avenue Pottier59130 LAMBERSART)

Abstract: The present invention relates to a pharmaceutical composition comprising a compound se...